
The FDA approved at-home dexmedetomidine film for acute agitation in adults with schizophrenia, schizoaffective disorder, or bipolar I or II disorder.
Vestibular migraine may be a relatively new diagnostic entity, but a new study shows it impacts around 6 million US adults.



